Bulent Yilmaz

Internal Medicine

2450 Vinson Hwy SE
Milledgeville, GA 31061

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

Journal: Cancer medicine

Published: February 28, 2024

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

Journal: Journal of immunotherapy and precision oncology

Published: January 25, 2024

Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.

Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.

Journal: Cancer medicine

Published: September 05, 2023

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.

Journal: Cancer

Published: November 23, 2022

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Journal: The oncologist

Published: October 16, 2022

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Journal: Cancer

Published: September 30, 2022

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.

Journal: Gynecologic oncology

Published: May 24, 2022

Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis.

Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis.

Journal: Journal of immunotherapy and precision oncology

Published: October 15, 2021

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.

Journal: The oncologist

Published: November 11, 2020

Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy.

Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy.

Journal: Journal of immunotherapy and precision oncology

Published: June 01, 2020

Polymorphisms in the IL28B gene (rs12979860, rs8099917) and the virological response to pegylated interferon therapy in hepatitis D virus patients.

Polymorphisms in the IL28B gene (rs12979860, rs8099917) and the virological response to pegylated interferon therapy in hepatitis D virus patients.

Journal: Acta gastro-enterologica Belgica

Published: July 08, 2016

Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?

Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?

Journal: European journal of gastroenterology & hepatology

Published: March 25, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026